Models of care for motor neuron disease: setting standards

被引:19
|
作者
Hardiman, O
Traynor, BJ
Corr, B
Frost, E
机构
[1] Beaumont Hosp, Dept Neurol, Dublin 9, Ireland
[2] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
来源
AMYOTROPHIC LATERAL SCLEROSIS | 2002年 / 3卷 / 04期
关键词
standard of care; ALS; management of ALS; therapy of ALS; healthcare delivery;
D O I
10.1080/146608202760839002
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Models of care for people with motor neuron disease (MND) must be designed in a patient-centered format, with an inbuilt flexibility and responsiveness that reflect the evolving nature of the condition. Diagnosis should be made as early as possible. Patients should have early access to centres with specialist knowledge of amyotrophic lateral sclerosis (ALS). Services should be flexible and responsive to the needs of the patient, and operate to best advantage when functioning as a coordinated team that cross-refers internally. Patients with ALS should be empowered to make rational end-of-life decisions based on maximizing quality of life and maintaining dignity. All models of care should be designed to cater for the sudden change from health to chronic illness, and should aim to provide a core of specialties that are patient-oriented, flexible and responsive. Ultimately, models of care should be assessed based on their outcomes.
引用
收藏
页码:182 / 185
页数:4
相关论文
共 50 条
  • [1] Motor neuron disease and animal models
    Price, DL
    Wong, PC
    Pardo, CA
    Borchelt, DR
    Lee, MK
    Becher, MW
    Griffin, JW
    Cork, LC
    Cleveland, DW
    Jenkins, NA
    Copeland, NG
    Sisodia, SS
    AMYOTROPHIC LATERAL SCLEROSIS: PROGRESS AND PERSPECTIVES IN BASIC RESEARCH AND CLINICAL APPLICATION, 1996, 1104 : 300 - 309
  • [2] Animal models for motor neuron disease
    Green, SL
    Tolwani, RJ
    LABORATORY ANIMAL SCIENCE, 1999, 49 (05): : 480 - 487
  • [3] SYMPTOMATIC CARE IN MOTOR NEURON DISEASE
    不详
    BRITISH MEDICAL JOURNAL, 1976, 2 (6036): : 605 - 606
  • [4] Survival prediction models in motor neuron disease
    Spinelli, Edoardo
    Agosta, Federica
    Riva, Nilo
    Fontana, Andrea
    Basaia, Silvia
    Canu, Elisa
    Castelnovo, Veronica
    Falzone, Yuri
    Carrera, Paola
    Comi, Giancarlo
    Filippi, Massimo
    NEUROLOGY, 2019, 92 (15)
  • [5] Toxic models of upper motor neuron disease
    Ludolph, AC
    Spencer, PS
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 139 : 53 - 59
  • [6] Survival prediction models in motor neuron disease
    Spinelli, E. G.
    Agosta, F.
    Riva, N.
    Fontana, A.
    Basaia, S.
    Canu, E.
    Castelnovo, V.
    Falzone, Y.
    Carrera, P.
    Comi, G.
    Filippi, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 309 - 309
  • [7] Survival prediction models in motor neuron disease
    Agosta, F.
    Spinelli, E. G.
    Riva, N.
    Fontana, A.
    Basaia, S.
    Canu, E.
    Castelnovo, V.
    Falzone, Y.
    Carrera, P.
    Comi, G.
    Filippi, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 (09) : 1143 - 1152
  • [8] Impact of PTEN modulation on motor neuron survival in experimental models of motor neuron disease
    Ismail, A.
    Ning, K.
    Sharrack, B.
    Azzouz, M.
    HUMAN GENE THERAPY, 2011, 22 (10) : A62 - A62
  • [9] Mechanisms of selective motor neuron death in transgenic mouse models of motor neuron disease
    Cleveland, DW
    Bruijn, LI
    Wong, PC
    Marszalek, JR
    Vechio, JD
    Lee, MK
    Xu, XS
    Borchelt, DR
    Sisodia, SS
    Price, DL
    NEUROLOGY, 1996, 47 (04) : S54 - S61
  • [10] MOTOR NEURON DISEASE - TOWARDS BETTER CARE
    PENTLAND, B
    BURFORD, K
    MITCHELL, JD
    BRITISH MEDICAL JOURNAL, 1985, 291 (6494): : 546 - 546